To quantify the financial cost of pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc). Methods: Healthcare use was captured through data linkage, wherein clinical data for SSc patients enrolled in the Australian Scleroderma Cohort Study were linked with hospital, emergency department (ED) and ambulatory care databases (MBS) for the period 2008–2015. |